Stay Up to Date
with SHINE

Nuclear fusion technology could play a key role in answering those questions.

SHINE today announced the company has submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration for non-carrier-added lutetium-177 (Lu-177) chloride, a radiopharmaceutical at the forefront of precision cancer treatment.

The most prominent players in the domestic molybdenum-99 realm converged on the Midwest this week, including making a stop at SHINE Technologies in Janesville.

The long-range vision is to develop an affordable and sustainable solution for fusion energy. But to get there, we are building on our technological capabilities, delivering value, and doing our best to make the world a safer, healthier, cleaner place through near-term fusion applications. Read the full article.

SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced CEO and founder Greg Piefer will give an invited presentation at the Wisconsin Entrepreneurs’ Conference in Milwaukee.

SHINE Technologies is working with Homeland Security. VP of Marketing and Communications, Patrick O’Connell joins the show with details.

As SHINE Technologies moves toward medical isotope production in Janesville, the company is fast pivoting into other areas.

New project develops neutron-based technology to detect and identify illegal narcotics and contraband in commercial cargo at ports of entry

SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced the appointments of global technology, energy sector and business veterans Holli C. Ladhani and Janet S. Wong to the company’s board of directors.

Janesville International Education Program wins annual competition; SHINE CEO honors Daniel Arizaga with prestigious ‘Illuminator Award’

SHINE founder and CEO Greg Piefer was invited to be part of the White House Summit, Developing a Bold Decadal Vision for Commercial Fusion Energy.

Tune in via livestream as Greg Piefer joins other industry experts to help shape vision for commercial fusion energy

SHINE to supply n.c.a. Lu-177 for the clinical development of ImaginAb investigational radiopharmaceuticals

To answer “how nuclear fusion works,” perhaps we should first ask, “how does the sun work?”

A neutron beam is a focused stream of neutrons. However, neutron emitters tend to release neutrons in all directions instead of just in a focused neutron beam, so special technology has to be employed to wrangle the neutrons into shape.